SECsense Logo

Context Therapeutics Inc. 8-K Filing Insights - January 14, 2025

$CNTX
Form 8-K
Filed on: 2025-01-14
Source
Context Therapeutics Inc. 8-K Filing Insights - January 14, 2025

Here are the key insights extracted from the provided section of the financial report:

  1. Company Information:
  • Name: Context Therapeutics Inc.
  • CIK (Central Index Key): 0001842952
  • Exchange: NASDAQ
  • Ticker Symbol: CNTX
  • Business Address: 2001 Market Street, Suite 3915 Unit #15, Philadelphia, PA 19103
  • Phone Number: (267) 225-7416
  • Entity Type: Delaware Corporation (DE)
  1. Filing Details:
  • Filing Type: 8-K
  • Filing Date: January 14, 2025
  1. Financial Reporting Context:
  • Reporting Period: The report covers a single day, from January 14, 2025, to January 14, 2025.
  1. SEC Filing Structure:
  • The document is formatted in XBRL (eXtensible Business Reporting Language), which is a standardized format for financial reporting.
  1. Tax Identification:
  • EIN (Employer Identification Number): 86-3738787

This information highlights the company's basic profile, the nature of the SEC filing, and the specifics of the reporting context, which is essential for understanding the financial state or events being reported.